Challenges in the diagnosis of polymyalgia rheumatica and related giant cell arteritis

References

• González-Gay MA, Matteson EL, Castañeda S. Polymyalgia rheumatica. Lancet. 2017;390:1700–1712. 10.1016/S0140-6736(17)31825-1.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Cantini F, Boiardi L, et al. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261–271.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Lopez-Diaz MJ, et al. Epidemiology of giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 2009;61:1454–1461.
   PubMed Web of Science ®Google Scholar
• Lundberg IE, Sharma A, Turesson C, et al. An update on polymyalgia rheumatica. J Intern Med. 2022;292:717–732.
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Rodríguez-Valverde V, Blanco R, et al. Polymyalgia rheumatica without significantly increased erythrocyte sedimentation rate. A more benign syndrome. Arch Intern Med. 1997;157:317–320.
   PubMedGoogle Scholar
• Manzo C, Milchert M, Natale M, et al. Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis. Rheumatology (Oxford). 2019;58:921–923.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA. Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. Semin Arthritis Rheum. 2004;33:289–293.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Castañeda S, Llorca J. Giant Cell Arteritis: visual Loss is Our Major Concern. J Rheumatol. 2016;43:1458–1461. 10.3899/jrheum.160466. .
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Vazquez-Rodriguez TR, Gomez-Acebo I, et al. Strokes at time of disease diagnosis in a series of 287 patients with biopsy-proven giant cell arteritis. Medicine (Baltimore). 2009;88:227–235.
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Prieto-Peña D, Martínez-Rodríguez I, et al. Early large vessel systemic vasculitis in adults. Best Pract Res Clin Rheumatol. 2019;33:101424.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, et al. The spectrum of conditions mimicking polymyalgia rheumatica in Northwestern Spain. J Rheumatol. 2000;27:2179–2184.
   PubMed Web of Science ®Google Scholar
• Elling P, Olsson AT, Elling H. Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. J Rheumatol. 1996;23:112–119.
   PubMed Web of Science ®Google Scholar
• Doran MF, Crowson CS, O’fallon WM, et al. Trends in the incidence of polymyalgia rheumatica over a 30 year period in Olmsted County, Minnesota, USA. J Rheumatol. 2002;29:1694–1697.
   PubMed Web of Science ®Google Scholar
• Schaufelberger C, Bengtsson BA, Andersson R. Epidemiology and mortality in 220 patients with polymyalgia rheumatica. Br J Rheumatol. 1995;34:261–264.
   PubMedGoogle Scholar
• González-Gay MA, García-Porrúa C, Vázquez-Caruncho M, et al. The spectrum of polymyalgia rheumatica in northwestern Spain: incidence and analysis of variables associated with relapse in a 10 year study. J Rheumatol. 1999;26:1326–1332.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Macchioni P, Zizzi F, et al. Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. Arthritis Rheum. 1991;34:351–356.
   PubMed Web of Science ®Google Scholar
• Sharma A, Mohammad AJ, Turesson C. Incidence and prevalence of giant cell arteritis and polymyalgia rheumatica: a systematic literature review. Semin Arthritis Rheum. 2020;50:1040–1048.
   PubMed Web of Science ®Google Scholar
• Pease CT, Haugeberg G, Montague B, et al. Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study. Rheumatology (Oxford). 2009;48:123–127.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Cantini F, Macchioni P, et al. Distal musculoskeletal manifestations in polymyalgia rheumatica: a prospective followup study. Arthritis Rheum. 1998;41:1221–1226.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Gabriel S, Hunder GG. Distal extremity swelling with pitting edema in polymyalgia rheumatica. Report on nineteen cases. Arthritis Rheum. 1996;39:73–80.
   PubMed Web of Science ®Google Scholar
• McCarthy EM, MacMullan PA, Al-Mudhaffer S, et al. Plasma fibrinogen is an accurate marker of disease activity in patients with polymyalgia rheumatica. Rheumatology (Oxford). 2013;52:465–471.
   PubMed Web of Science ®Google Scholar
• McCarthy EM, MacMullan PA, Al-Mudhaffer S, et al. Plasma fibrinogen along with patient-reported outcome measures enhances management of polymyalgia rheumatica: a prospective study. J Rheumatol. 2014;41:931–937.
   PubMed Web of Science ®Google Scholar
• Bird HA, Esselinckx W, Dixon AS, et al. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis. 1979;38:434–439.
   PubMed Web of Science ®Google Scholar
• Jones JG, Hazleman BL. Prognosis and management of polymyalgia rheumatica. Ann Rheum Dis. 1981;40:1–5.
   PubMed Web of Science ®Google Scholar
• Chuang TY, Hunder GG, Ilstrup DM, et al. Polymyalgia rheumatica: a 10-year epidemiologic and clinical study. Ann Intern Med. 1982;97:672–680.
   PubMed Web of Science ®Google Scholar
• Healey LA. Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. Semin Arthritis Rheum. 1984;13:322–328.
   PubMed Web of Science ®Google Scholar
• Dasgupta B, Cimmino MA, Kremers HM, et al. Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheum. 2012;64:943–954.
   PubMed Web of Science ®Google Scholar
• Macchioni P, Boiardi L, Catanoso M, et al. Performance of the new 2012 EULAR/ACR classification criteria for polymyalgia rheumatica: comparison with the previous criteria in a single-centre study. Ann Rheum Dis. 2014;73:1190–1193.
   PubMed Web of Science ®Google Scholar
• Fors C, Bergström U, Willim M, et al. Validity of polymyalgia rheumatica diagnoses and classification criteria in primary health care. Rheumatol Adv Pract. 2019;3:rkz033.
   PubMedGoogle Scholar
• Milchert M, Brzosko M. Diagnosis of polymyalgia rheumatica usually means a favourable outcome for your patient. Indian J Med Res. 2017;145:593–600.
   PubMed Web of Science ®Google Scholar
• Myklebust G, Gran JT. A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis. Br J Rheumatol. 1996;35:1161–1168.
   PubMedGoogle Scholar
• Cantini F, Salvarani C, Olivieri I, et al. Erythrocyte sedimentation rate and C-reactive protein in the evaluation of disease activity and severity in polymyalgia rheumatica: a prospective follow-up study. Semin Arthritis Rheum. 2000;30:17–24.
   PubMed Web of Science ®Google Scholar
• Proven A, Gabriel SE, O’fallon WM, et al. Polymyalgia rheumatica with low erythrocyte sedimentation rate at diagnosis. J Rheumatol. 1999;26:1333–1337.
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Pina T. Giant cell arteritis and polymyalgia rheumatica: an update. Curr Rheumatol Rep. 2015;17:6.
   PubMed Web of Science ®Google Scholar
• Dasgupta B, Panayi GS. Interleukin-6 in serum of patients with polymyalgia rheumatica and giant cell arteritis. Br J Rheumatol. 1990;29:456–458.
   PubMedGoogle Scholar
• Pipitone N, Salvarani C. Update on polymyalgia rheumatica. Eur J Intern Med. 2013;24:583–589.
   PubMed Web of Science ®Google Scholar
• González-Gay MA, García-Porrúa C, Salvarani C, et al. Polymyalgia manifestations in different conditions mimicking polymyalgia rheumatica. Clin Exp Rheumatol. 2000;18:755–759.
   PubMed Web of Science ®Google Scholar
• Dejaco C, Duftner C, Buttgereit F, et al. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology (Oxford). 2017;56:506–515.
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Alonso MD, Agüero JJ, et al. Temporal arteritis in a northwestern area of Spain: study of 57 biopsy proven patients. J Rheumatol. 1992;19:277–280.
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Amoli MM, Garcia-Porrua C, et al. Genetic markers of disease susceptibility and severity in giant cell arteritis and polymyalgia rheumatica. Semin Arthritis Rheum. 2003;33:38–48.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Miranda-Filloy JA, Lopez-Diaz MJ, et al. Giant cell arteritis in northwestern Spain: a 25-year epidemiologic study. Medicine (Baltimore). 2007;86:61–68.
   PubMed Web of Science ®Google Scholar
• Burg LC, Karakostas P, Behning C, et al. Prevalence and characteristics of giant cell arteritis in patients with newly diagnosed polymyalgia rheumatica - a prospective cohort study. Ther Adv Musculoskelet Dis. 2023;15:1759720X221149963.
   PubMed Web of Science ®Google Scholar
• González-Gay MA, Garcia-Porrua C, Rivas MJ, et al. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain: trend over an 18 year period. Ann Rheum Dis. 2001;60:367–371.
   PubMed Web of Science ®Google Scholar
• González-Gay MA, García-Porrúa C, Vázquez-Caruncho M. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica. J Rheumatol. 1998;25:1750–1755.
   PubMed Web of Science ®Google Scholar
• Prieto-Peña D, Martínez-Rodríguez I, Loricera J, et al. Predictors of positive 18F-FDG PET/CT-scan for large vessel vasculitis in patients with persistent polymyalgia rheumatica. Semin Arthritis Rheum. 2019;48:720–727.
   PubMed Web of Science ®Google Scholar
• Narváez J, Estrada P, López-Vives L, et al. Prevalence of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica. Semin Arthritis Rheum. 2015;45:328–333.
   PubMed Web of Science ®Google Scholar
• Dejaco C, Ramiro S, Duftner C, et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis. 2018;77:636–643.
   PubMed Web of Science ®Google Scholar
• Bull Haaversen AC, Brekke LK, Kermani TA, et al. Extended ultrasound examination identifies more large vessel involvement in patients with giant cell arteritis. Rheumatology (Oxford). 2022;keac478.
   PubMed Web of Science ®Google Scholar
• Prieto-Peña D, Castañeda S, Martínez-Rodríguez I, et al. Imaging tests in the early diagnosis of giant cell arteritis. J Clin Med. 2021;10:3704.
   PubMed Web of Science ®Google Scholar
• Hemmig AK, Gozzoli D, Werlen L, et al. Subclinical giant cell arteritis in new onset polymyalgia rheumatica a systematic review and meta-analysis of individual patient data. Semin Arthritis Rheum. 2022 Aug;55:152017.
   PubMed Web of Science ®Google Scholar
• Kermani TA, Warrington KJ. Advances and challenges in the diagnosis and treatment of polymyalgia rheumatica. Ther Adv Musculoskelet Dis. 2014;6:8–19.
   PubMedGoogle Scholar
• Cantini F, Salvarani C, Olivieri I, et al. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study. Ann Rheum Dis. 1999;58:230–236.
   PubMed Web of Science ®Google Scholar
• Olivieri I, D’angelo S, Palazzi C, et al. Late-onset spondyloarthritis: subset that should not be forgotten. J Rheumatol. 2012;39:1110–1112.
   PubMed Web of Science ®Google Scholar
• Olivieri I, Garcia-Porrua C, Padula A, et al. Late onset undifferentiated spondyloarthritis presenting with polymyalgia rheumatica features: description of seven cases. Rheumatol Int. 2007;27:927–933.
   PubMed Web of Science ®Google Scholar
• Pego-Reigosa JM, Rodriguez-Rodriguez M, Hurtado-Hernandez Z, et al. Calcium pyrophosphate deposition disease mimicking polymyalgia rheumatica: a prospective followup study of predictive factors for this condition in patients presenting with polymyalgia symptoms. Arthritis Rheum. 2005;53:931–938.
   PubMedGoogle Scholar
• Salvarani C, Cantini F, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. Lancet. 2008;372:234–245.
   PubMed Web of Science ®Google Scholar
• Salvarani C, Gabriel SE, Gertz MA, et al. Primary systemic amyloidosis presenting as giant cell arteritis and polymyalgia rheumatica. Arthritis Rheum. 1994;37:1621–1626.
   PubMed Web of Science ®Google Scholar
• Dejaco C, Singh YP, Perel P, et al. 2015 recommendations for the management of polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Arthritis Rheumatol. 2015;67:2569–2580.
   PubMed Web of Science ®Google Scholar
• Kostine M, Rouxel L, Barnetche T, et al. Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study. Ann Rheum Dis. 2018;77:393–398.
   PubMed Web of Science ®Google Scholar
• Calabrese C, Cappelli LC, Kostine M, et al. Polymyalgia rheumatica-like syndrome from checkpoint inhibitor therapy: case series and systematic review of the literature. RMD Open. 2019;5:e000906.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Mazón I, Sánchez-Bilbao L, Martín-Varillas JL, et al. Immune-related adverse events in patients with solid-organ tumours treated with immunotherapy: a 3-year study of 102 cases from a single centre. Clin Exp Rheumatol. 2021;39:612–620.
   PubMed Web of Science ®Google Scholar
• Kostine M, Finckh A, Bingham CO, et al. EULAR points to consider for the diagnosis and management of rheumatic immune-related adverse events due to cancer immunotherapy with checkpoint inhibitors. Ann Rheum Dis. 2021;80:36–48.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Salvarani C, et al. Diagnostic approach in a patient presenting with polymyalgia. Clin Exp Rheumatol. 1999;17:276–278.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Amor-Dorado JC, et al. Fever in biopsy-proven giant cell arteritis: clinical implications in a defined population. Arthritis Rheum. 2004;51:652–655.
   PubMedGoogle Scholar
• Gonzalez-Gay MA, Garcia-Porrua C, Miranda-Filloy JA, et al. Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management. Drugs Aging. 2006;23(8):627–649. DOI:10.2165/00002512-200623080-00002
   PubMed Web of Science ®Google Scholar